Infant Formula Bill Would Expand FDA Oversight of Inspections

The FDA would need to inspect infant formula manufacturing facilities at least every six months under a bill that aims to hold the agency accountable for its actions leading up to the nationwide shortage.

The measure, obtained by Bloomberg Law, would give the Food and Drug Administration expanded authority to conduct unannounced inspections on formula plants and require manufacturers to alert the FDA once they become aware of situations that could lead to shortages.

House Appropriations Chairwoman Rosa DeLauro (D-Conn.) introduced the legislation Friday to prevent future safety issues. Lawmakers and watchdogs are examining the FDA’s response to reports ...